CN103041134A - Traditional Chinese medicine composition for treating vital myocarditis - Google Patents
Traditional Chinese medicine composition for treating vital myocarditis Download PDFInfo
- Publication number
- CN103041134A CN103041134A CN201210597026XA CN201210597026A CN103041134A CN 103041134 A CN103041134 A CN 103041134A CN 201210597026X A CN201210597026X A CN 201210597026XA CN 201210597026 A CN201210597026 A CN 201210597026A CN 103041134 A CN103041134 A CN 103041134A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- herba
- chinese medicine
- medicine composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 28
- 239000000203 mixture Substances 0.000 title claims abstract description 14
- 208000009525 Myocarditis Diseases 0.000 title abstract description 5
- 235000011201 Ginkgo Nutrition 0.000 claims abstract description 12
- 235000008100 Ginkgo biloba Nutrition 0.000 claims abstract description 12
- 238000010438 heat treatment Methods 0.000 claims description 14
- 206010047470 viral myocarditis Diseases 0.000 claims description 14
- 241000218628 Ginkgo Species 0.000 claims description 11
- 241000921449 Rhodobryum roseum Species 0.000 claims description 11
- 239000002994 raw material Substances 0.000 claims description 4
- 241000245240 Lonicera Species 0.000 claims description 2
- 241000219295 Portulaca Species 0.000 claims description 2
- 241000792914 Valeriana Species 0.000 claims description 2
- 235000017468 valeriana Nutrition 0.000 claims description 2
- 241000185686 Apocynum venetum Species 0.000 abstract 1
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 235000009024 Ceanothus sanguineus Nutrition 0.000 abstract 1
- 240000005717 Dioscorea alata Species 0.000 abstract 1
- 244000194101 Ginkgo biloba Species 0.000 abstract 1
- 240000003553 Leptospermum scoparium Species 0.000 abstract 1
- 241000234435 Lilium Species 0.000 abstract 1
- 235000015459 Lycium barbarum Nutrition 0.000 abstract 1
- 240000001659 Oldenlandia diffusa Species 0.000 abstract 1
- 244000234609 Portulaca oleracea Species 0.000 abstract 1
- 235000001855 Portulaca oleracea Nutrition 0.000 abstract 1
- 241000921453 Rhodobryum Species 0.000 abstract 1
- 241000304195 Salvia miltiorrhiza Species 0.000 abstract 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 abstract 1
- 244000126014 Valeriana officinalis Species 0.000 abstract 1
- 235000013832 Valeriana officinalis Nutrition 0.000 abstract 1
- 235000016788 valerian Nutrition 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 description 9
- 206010011224 Cough Diseases 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 231100000614 poison Toxicity 0.000 description 8
- 208000002193 Pain Diseases 0.000 description 7
- 230000017531 blood circulation Effects 0.000 description 7
- 210000000038 chest Anatomy 0.000 description 7
- 201000010099 disease Diseases 0.000 description 7
- 230000036407 pain Effects 0.000 description 7
- 239000003440 toxic substance Substances 0.000 description 7
- 235000009508 confectionery Nutrition 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 230000002936 tranquilizing effect Effects 0.000 description 5
- 206010033557 Palpitations Diseases 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 230000005906 menstruation Effects 0.000 description 4
- 230000007958 sleep Effects 0.000 description 4
- 208000006820 Arthralgia Diseases 0.000 description 3
- 206010007247 Carbuncle Diseases 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 208000025747 Rheumatic disease Diseases 0.000 description 3
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 3
- 206010003119 arrhythmia Diseases 0.000 description 3
- 230000006793 arrhythmia Effects 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 206010022437 insomnia Diseases 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 230000001047 pyretic effect Effects 0.000 description 3
- 230000000552 rheumatic effect Effects 0.000 description 3
- 206010040872 skin infection Diseases 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 206010003011 Appendicitis Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 208000015220 Febrile disease Diseases 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 208000000418 Premature Cardiac Complexes Diseases 0.000 description 2
- 208000036142 Viral infection Diseases 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 208000019622 heart disease Diseases 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- 238000005096 rolling process Methods 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 230000009385 viral infection Effects 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010001115 Adams-Stokes syndrome Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 206010006578 Bundle-Branch Block Diseases 0.000 description 1
- 206010007556 Cardiac failure acute Diseases 0.000 description 1
- 206010007559 Cardiac failure congestive Diseases 0.000 description 1
- 208000006029 Cardiomegaly Diseases 0.000 description 1
- 208000031229 Cardiomyopathies Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010054787 Haemorrhoidal haemorrhage Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 208000007514 Herpes zoster Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 206010024453 Ligament sprain Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 206010040007 Sense of oppression Diseases 0.000 description 1
- 206010040736 Sinoatrial block Diseases 0.000 description 1
- 206010067868 Skin mass Diseases 0.000 description 1
- 208000010040 Sprains and Strains Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 208000009729 Ventricular Premature Complexes Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 239000003416 antiarrhythmic agent Substances 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 206010007625 cardiogenic shock Diseases 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000008828 contractile function Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 208000028659 discharge Diseases 0.000 description 1
- 230000009429 distress Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 229960003444 immunosuppressant agent Drugs 0.000 description 1
- 230000001861 immunosuppressant effect Effects 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 230000003680 myocardial damage Effects 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000001314 paroxysmal effect Effects 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 206010047302 ventricular tachycardia Diseases 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A traditional Chinese medicine composition for treating vital myocarditis is prepared by red rhodobryum, purslane, honeysuckle stem, folium ginkgo, valerian, peltate yam rhizome, oldenlandia diffusa, lily, tea tree roots, salvia miltiorrhiza and apocynum venetum. The composition can be clinically used for treating the vital myocarditis.
Description
Technical field
The invention belongs to technical field of Chinese medicines, especially relate to a kind of Chinese medicine composition for the treatment of viral myocarditis.
Background technology
Viral myocarditis refers to the acute or chronic myocarditis disease that caused by various viruses, and is in the majority with child and the adult below 40 years old.Wherein, 35% patient falls ill between 10-30 year, and adult's age of onset is many in 31-35 year.Patient about 90% is chief complaint with arrhythmia or head sees symptom, common cardiopalmus, uncomfortable in chest, pareordia dull pain, dizziness, the symptom such as weak, can occur fainting even Adams Stokes syndrome, serious symptom diffusivity myocarditis can cause acute heart failure, easily merges cardiogenic shock or causes cardiomyopathy.Doctor trained in Western medicine there is no the specific treatment method at present, the clinical symptomatic treatments such as immunosuppressant, interferon and myocardial cell nutrient that adopt more.Draw through inventor's long-term practice, the Chinese medicine viral myocarditis of curing the disease has better effect, obtains good effect.
Summary of the invention
The Chinese medicine composition of the treatment viral myocarditis that the object of the present invention is to provide that a kind of therapeutic effect is good, effective percentage is high, human body is had no side effect.
The object of the present invention is achieved like this, according to Chinese medical theory, utilize the property of medicine of Chinese medicine uniqueness, adopt Rhodobryum roseum Limpr., Herba Portulacae, Caulis Lonicerae, Folium Ginkgo, Rhizoma et radix valerianae, duration and degree of heating root, Herba Hedyotidis Diffusae, Bulbus Lilii, Radix Camelliae sinensis, Radix Salviae Miltiorrhizae, Herba Apocyni veneti according to certain compatibility requirement, through being processed into.
Prepare Chinese medicine composition of the present invention and make Rhodobryum roseum Limpr. 40-60 part, Herba Portulacae 20-30 part, Caulis Lonicerae 20-30 part by following raw material medicaments, Folium Ginkgo 20-30 part, Rhizoma et radix valerianae 15-30 part, duration and degree of heating root 15-25 part, Herba Hedyotidis Diffusae 10-20 part, Bulbus Lilii 10-20 part, Radix Camelliae sinensis 10-20 part, Radix Salviae Miltiorrhizae 8-15 part, Herba Apocyni veneti 8-15 part.
Optimum weight part of traditional Chinese medicinal composition raw materials of the present invention is: 50 parts of Rhodobryum roseum Limpr.s, 25 parts of Herba Portulacaes, 25 parts of Caulis Loniceraes, 25 parts of Folium Ginkgos, 20 parts of Rhizoma et radix valerianaes, 20 parts of duration and degree of heating roots, 15 parts of Herba Hedyotidis Diffusaes, 15 parts of Bulbus Liliies, 15 parts of Radix Camelliae sinensiss, 10 parts of Radix Salviae Miltiorrhizaes, 10 parts of Herba Apocyni venetis.
The pharmacological action of Chinese medicine of the present invention is as follows:
Rhodobryum roseum Limpr.: light, little hardship, flat.The GUIXIN warp.Tranquilizing by nourishing the heart, calmness.Be used for heart disease, nervous, cardiopalmus severe palpitation, neurasthenia etc.
Herba Portulacae: sour, cold in nature.Return large intestine, Liver Channel.Heat-clearing and toxic substances removing, eliminating pathogenic heat from blood to cure dysentery, it is treating stranguria to dehumidify.Be used for the pyretic toxicity dysentery, pyretic stranguria, urine retention, leucorrhea with red and white discharge, metrorrhagia, hemorrhoidal bleeding, skin infection carbuncle furuncle etc.
Caulis Lonicerae: sweet, cold.GUIXIN, lung meridian.Heat-clearing and toxic substances removing, collateral dredging.Be used for epidemic febrile disease heating, ulcer sore pain, acute appendicitis, acute mastitis, toxic-heat and blood stasis, rheumatic arthralgia etc.
Folium Ginkgo: bitter, sweet, puckery, mild toxicity.GUIXIN, lung, spleen channel.Invigorate blood circulation and nourish heart, the astringing intestine to stop diarrhea of astringing the lung.Cure mainly obstruction of qi in the chest and cardialgia, the phlegmatic cough of breathing with cough, dysentery, leucorrhea etc.
Rhizoma et radix valerianae: hot, bitter, warm.GUIXIN, Liver Channel.Tranquilizing mind.Be used for irritability, palpitation and insomnia, demented, rheumatic arthralgia, dysmenorrhea, amenorrhea, the diseases such as traumatic injury.
Duration and degree of heating root: bitter, little sweet, cool.Clearing away lung-heat to relieve cough, dampness removing is treating stranguria, removing obstruction in the collateral to relieve pain, removing toxic substances and promoting subsidence of swelling.Be used for the cough due to lung-heat, damp and hot pouring pain, lumbago due to pathogenic wind-dampness, osteopatia sprain etc.
Herba Hedyotidis Diffusae: sweet, cold.GUIXIN, liver, spleen, large intestine channel.Heat-clearing and toxic substances removing, dampness removing.Be used for dyspnea and cough due to lung-heat, laryngopharynx swelling and pain, acute appendicitis, furuncle and phyma skin infection, venom, the puckery pain of pyretic stranguria etc.
Bulbus Lilii: sweet, little hardship is slightly cold GUIXIN, lung meridian.Nourishing YIN to relieve dryness, clearing away heart-fire for tranquillization.Cure mainly the fidgets due to deficiency palpitation with fear due to unsuccessful of deficiency of YIN chronic cough or feelings will, insomnia and dreamful sleep.
Radix Camelliae sinensis: bitter, cool.GUIXIN, kidney channel.Heart tonifying diuresis, promoting blood flow to regulate menstruation, heat-clearing and toxic substances removing.Be used for heart disease, edema, hepatitis, dysmenorrhea, aphtha, the diseases such as herpes zoster.
Radix Salviae Miltiorrhizae: bitter, be slightly cold.GUIXIN, Liver Channel.Promoting blood flow to regulate menstruation, the removing heat from blood eliminating carbuncle is calmed the nerves.Be used for the ambition, epigastric pain of blood stasis Ji lumps in the chest and abdomen, rheumatic arthralgia, skin infection carbuncle etc.
Herba Apocyni veneti: sweet, little hardship, cold.The heat clearing away suppressing the hyperactive liver, inducing diuresis to remove edema.Be used for hypertension, dizzy, headache, cardiopalmus, the diseases such as insomnia.
Viral myocarditis belongs to the categories such as the traditional Chinese medical science thoracic obstruction, cardiopalmus, palpitation with a distress feeling, epidemic febrile disease.Its sick position is at the heart, and is dirty relevant with lung spleen kidney three, and positive QI-insufficiency, evil poison are invaded the key that the heart is the primary disease morbidity.Rhodobryum roseum Limpr. has the effect of tranquilizing by nourishing the heart among the present invention, is monarch drug, Herba Portulacae, Caulis Lonicerae heat-clearing and toxic substances removing, collateral dredging, Folium Ginkgo is invigorated blood circulation and is nourished heart, the Rhizoma et radix valerianae tranquilizing mind is ministerial drug, duration and degree of heating root removing obstruction in the collateral to relieve pain, Herba Hedyotidis Diffusae heat-clearing and toxic substances removing, the Bulbus Lilii nourishing YIN to relieve dryness, the diuresis of Radix Camelliae sinensis heart tonifying, promoting blood flow to regulate menstruation, Radix Salviae Miltiorrhizae promoting blood flow to regulate menstruation, calm the nerves the Herba Apocyni veneti clearing away heat-fire.All medicines share that to play altogether clearing heat in YING system diathermanous, the detoxifcation yin nourishing, and promoting blood circulation to remove obstruction in the collateral, the effect of tranquilizing by nourishing the heart is found through clinical practice, and viral myocarditis is had unique curative effect.
Chinese medicine composition of the present invention was in 2006 to 2010 clinical observation viral myocarditis 80 routine patients, and clinical report is as follows:
1, physical data
Among the 80 routine patients, age 5-53 year, the course of disease is many at 20 days to 3 years, 23 years old mean age.
2, diagnostic criteria
" traditional Chinese medical science disease Standardization of diagnosis and curative effect " that diagnosis basis State Administration of Traditional Chinese Medicine issues:
Behind the viral infection such as upper respiratory tract infection, diarrhoea in 1-3 week or acute stage Cardiac Manifestation (such as DG, pericardium grating, cardiac dilatation etc.) and congestive heart failure or heart source property anoxia person appear.After the above-mentioned infection in 1-3 week or morbidity emerging various arrhythmia and following ECG change person before not taking antiarrhythmic drug, occurs simultaneously: (1) chamber or sinoatrial block, bundle branch block, (2) 2 above ST-Segments have unusually, be level or the declivity type moves down ST 〉=0.05mv, or a plurality of ST of leading raise unusually or the person that has the abnormality Q wave, (3) multiform that takes place frequently, paired or the concurrency premature beat of multi-source, short battle array, supraventricular or the ventricular tachycardia of paroxysmal, flutter or vibration etc., the T ripple that leads take the R ripple as main ripple more than (4) 2 is inverted, 1/10 of smooth or be reduced to 〉=R ripple, (5) taking place frequently property room early or the chamber early.It is namely diagnosable to have in above (1)-(3) any one, has (4) or (5), or will replenish following index to help diagnosis without obvious viral infection person: left chamber contractile function weakens or the course of disease has myocardium enzyme to increase in early days.
3, Therapeutic Method
3.1 prescription: Rhodobryum roseum Limpr. 50g, Herba Portulacae 25g, Caulis Lonicerae 25g, Folium Ginkgo 25g, Rhizoma et radix valerianae 20g, duration and degree of heating root 20g, Herba Hedyotidis Diffusae 15g, Bulbus Lilii 15g, Radix Camelliae sinensis 15g, Radix Salviae Miltiorrhizae 10g, Herba Apocyni veneti 10g.
3.2 method of preparation and use: said medicine routinely technique is made decoction, and 1 dose of every day, every day 2 times, 15 days was 1 course for the treatment of.
4, therapeutic outcome:
4.1 formulate with reference to " Chinese medicine Clinical Researches of New Drugs guideline ":
Cure: clinical symptoms, sign disappear, and it is normal that the inspection of laboratory indices recovers.
Produce effects: clinical symptoms, sign disappear substantially, and electrocardiogram, sero-enzyme recover normally substantially, and other have clear improvement.
Effectively: clinical symptoms, sign make moderate progress, and the laboratory indices has certain improvement.
Invalid: clinical symptoms, sign and laboratory indices are all without improving.
4.2 result: among the 80 routine patients, cure 70 examples (87.5%), produce effects 8 examples (10%), effective 2 examples (2.5%), invalid 0 example, total effective rate is 100%.
5, model case
5.1 the week certain, the woman, 16 years old, patient's cardiopalmus was uncomfortable in chest, breathed hard, and premature beat is arranged when conscious, and is weak, dreaminess, it is unreal to sleep, and sleeps less, the light red tongue point is red, tongue is white, irregularly rapid pulse.Electrocardio diagram: the chamber of taking place frequently early, premature ventricular beat, the heart shows frequently: accidental chamber early, myocardial damage, myocardial ischemia.Be diagnosed as viral myocarditis.Take medicine of the present invention, treat 1 course for the treatment of, symptom obviously alleviates, and sensation of oppression over the chest with shortness of breath is received food, and sleep takes a turn for the better, and strength increases, and continues to take 2 courses for the treatment of, and recovery from illness is followed up a case by regular visits to after half a year without recurrence.
5.2 Chen, the man, 42 years old, viral myocarditis medical history 2 years, in time, breathe hard, and is weak.Heating, cough appear a few days ago, continue then occur cardiopalmus, uncomfortable in chest, breathe hard, very weak.Tongue is dark red, and tongue is yellow in vain, and the rolling pulse rule is uneven.Electrocardio diagram: the chamber of taking place frequently early, the incomplete conduction block of right bundle branch, arrhythmia.Take medicine of the present invention, 1 dose of every day, after 1 course for the treatment of, symptom is clearly better, and heating, cough disappear, cardiopalmus, uncomfortable in chest, breathing hard alleviates, the time anorexia.Light red tongue, tongue is white, and rolling pulse continues to take 2 courses for the treatment of, and recovery from illness is followed up a case by regular visits to after 1 year without recurrence.
The specific embodiment
The present invention is further illustrated below in conjunction with embodiment, and following this embodiment only for explanation the present invention to the present invention without limits.
Embodiment 1, a kind of Chinese medicine composition for the treatment of viral myocarditis is to be made by Rhodobryum roseum Limpr. 40g, Herba Portulacae 20g, Caulis Lonicerae 20g, Folium Ginkgo 20g, Rhizoma et radix valerianae 15g, duration and degree of heating root 15g, Herba Hedyotidis Diffusae 10g, Bulbus Lilii 10g, Radix Camelliae sinensis 10g, Radix Salviae Miltiorrhizae 8g, Herba Apocyni veneti 8g.
Embodiment 2, a kind of Chinese medicine composition for the treatment of viral myocarditis is to be made by Rhodobryum roseum Limpr. 50g, Herba Portulacae 25g, Caulis Lonicerae 25g, Folium Ginkgo 25g, Rhizoma et radix valerianae 20g, duration and degree of heating root 20g, Herba Hedyotidis Diffusae 15g, Bulbus Lilii 15g, Radix Camelliae sinensis 15g, Radix Salviae Miltiorrhizae 10g, Herba Apocyni veneti 10g.
Embodiment 3, a kind of Chinese medicine composition for the treatment of viral myocarditis is to be made by Rhodobryum roseum Limpr. 60g, Herba Portulacae 30g, Caulis Lonicerae 30g, Folium Ginkgo 30g, Rhizoma et radix valerianae 30g, duration and degree of heating root 25g, Herba Hedyotidis Diffusae 20g, Bulbus Lilii 20g, Radix Camelliae sinensis 20g, Radix Salviae Miltiorrhizae 15g, Herba Apocyni veneti 15g.
Claims (2)
1. Chinese medicine composition for the treatment of viral myocarditis is characterized in that it is to be made by following raw material medicaments:
Rhodobryum roseum Limpr. 40-60 part, Herba Portulacae 20-30 part, Caulis Lonicerae 20-30 part, Folium Ginkgo 20-30 part, Rhizoma et radix valerianae 15-30 part, duration and degree of heating root 15-25 part, Herba Hedyotidis Diffusae 10-20 part, Bulbus Lilii 10-20 part, Radix Camelliae sinensis 10-20 part, Radix Salviae Miltiorrhizae 8-15 part, Herba Apocyni veneti 8-15 part.
2. Chinese medicine composition according to claim 1 is characterized in that it is to be made by following raw material medicaments:
50 parts of Rhodobryum roseum Limpr.s, 25 parts of Herba Portulacaes, 25 parts of Caulis Loniceraes, 25 parts of Folium Ginkgos, 20 parts of Rhizoma et radix valerianaes, 20 parts of duration and degree of heating roots, 15 parts of Herba Hedyotidis Diffusaes, 15 parts of Bulbus Liliies, 15 parts of Radix Camelliae sinensiss, 10 parts of Radix Salviae Miltiorrhizaes, 10 parts of Herba Apocyni venetis.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210597026XA CN103041134B (en) | 2012-12-31 | 2012-12-31 | Traditional Chinese medicine composition for treating vital myocarditis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210597026XA CN103041134B (en) | 2012-12-31 | 2012-12-31 | Traditional Chinese medicine composition for treating vital myocarditis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103041134A true CN103041134A (en) | 2013-04-17 |
| CN103041134B CN103041134B (en) | 2013-12-11 |
Family
ID=48054145
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210597026XA Expired - Fee Related CN103041134B (en) | 2012-12-31 | 2012-12-31 | Traditional Chinese medicine composition for treating vital myocarditis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103041134B (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104189598A (en) * | 2014-09-18 | 2014-12-10 | 邓新连 | Traditional Chinese medicine for treating qi stagnation and blood stasis type viral myocarditis |
| CN105213992A (en) * | 2015-10-23 | 2016-01-06 | 李文友 | The medicine for the treatment of viral myocarditis |
| CN105998684A (en) * | 2016-06-07 | 2016-10-12 | 全运明 | Traditional Chinese medicine decoction for treating myocarditis |
-
2012
- 2012-12-31 CN CN201210597026XA patent/CN103041134B/en not_active Expired - Fee Related
Non-Patent Citations (1)
| Title |
|---|
| 吴新富 等: "病毒性心肌炎中医药治疗研究近况", 《江西中医学院学报》 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104189598A (en) * | 2014-09-18 | 2014-12-10 | 邓新连 | Traditional Chinese medicine for treating qi stagnation and blood stasis type viral myocarditis |
| CN105213992A (en) * | 2015-10-23 | 2016-01-06 | 李文友 | The medicine for the treatment of viral myocarditis |
| CN105998684A (en) * | 2016-06-07 | 2016-10-12 | 全运明 | Traditional Chinese medicine decoction for treating myocarditis |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103041134B (en) | 2013-12-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104208245B (en) | Tinea manus and pedis Traditional Chinese medicine medicated bath and preparation method | |
| CN103191291B (en) | Traditional Chinese medicine composition for treating viral myocarditis | |
| CN104189789A (en) | Traditional Chinese medicine composition for treating acute infectious jaundice type hepatitis | |
| CN103126415A (en) | Neck guard and blood pressure reducing drug pillow | |
| CN104940810A (en) | Traditional Chinese medicine composition for treating angina | |
| CN103041134B (en) | Traditional Chinese medicine composition for treating vital myocarditis | |
| CN103520443B (en) | Traditional Chinese medicinal preparation for treating adult viral myocarditis and preparation method for traditional Chinese medicinal preparation | |
| CN104069446A (en) | Traditional Chinese medicine composition for treating angina pectoris | |
| CN106334171B (en) | A kind of Chinese medicine preparation and preparation method for being used to repair hepatic injury | |
| CN103520474A (en) | Traditional Chinese medicinal preparation for treating viral myocarditis | |
| CN102406893A (en) | Chinese patent medicine for treating psoriasis. | |
| CN105560736A (en) | Traditional Chinese medicine composition for treating herpes zoster | |
| CN105311460A (en) | Traditional Chinese medicine for treating vascular neuralgia headache | |
| CN103638428A (en) | Traditional Chinese medicinal composition for treating coronary heart disease | |
| CN103566158A (en) | Traditional Chinese medicine composition used for curing viral myocarditis | |
| CN103800723B (en) | One is used for the treatment of ARR Chinese medicine composition and preparation method thereof | |
| CN102552789A (en) | Chinese medicine for treating damp-warm flu and preparation method and application thereof | |
| CN101983712A (en) | Novel medicament for treating coronary heart disease | |
| CN106267127A (en) | A kind of Chinese medicine composition treating lumbago and skelalgia arthromyodynia and heat steam health promoting insoles | |
| CN102049005A (en) | Chinese medicinal preparation for treating coronary heart diseases | |
| CN105727243A (en) | Chinese herbal composition for treating myocarditis and preparing method of Chinese herbal composition | |
| CN105079394A (en) | Pharmaceutic preparation for treating arrhythmia | |
| CN103272072B (en) | Chinese medicinal composition for treating psoriasis | |
| CN104740516A (en) | Traditional Chinese medicine for treating coronary heart disease | |
| CN105688057A (en) | Traditional Chinese medicine composition for treating viral myocarditis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C56 | Change in the name or address of the patentee | ||
| CP02 | Change in the address of a patent holder |
Address after: 225300 Jiangsu Province, Taizhou high tech Industrial Park, Yong Sheng Road, No. 6 Patentee after: Zheng Xueqin Address before: 262500 Shandong province Qingzhou City Linglong Mountain Road No. 3888 Qingzhou Invalides hospital Patentee before: Zheng Xueqin |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20170427 Address after: 225300 Jiangsu Province, Taizhou high tech Industrial Park, Yong Sheng Road, No. 6 Patentee after: Wang Lihua Address before: 225300 Jiangsu Province, Taizhou high tech Industrial Park, Yong Sheng Road, No. 6 Patentee before: Zheng Xueqin |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20190923 Address after: Room 501, Office Building of Market Supervision Bureau of Langchuan Avenue, Jianping Town, Langxi County, Xuancheng City, Anhui Province Patentee after: Xuancheng Geith Intellectual Property Operations Co., Ltd. Address before: 225300 Jiangsu Province, Taizhou high tech Industrial Park, Yong Sheng Road, No. 6 Patentee before: Wang Li Hua |
|
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20131211 Termination date: 20191231 |